Please sign in to follow a disease.
Acquired coagulation factor deficiency
MONDO:0020599Deficiency of a coagulation factor that is not caused by genetic alterations. Causes include vitamin K deficiency, amyloidosis, and severe liver disease.
Also known as: acquired coagulation factor deficiency, acquired coagulation protein disease
20 clinical trials for this condition and its sub-types, 4 tagged with Acquired coagulation factor deficiency itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Acquired coagulation factor deficiency
-
Acquired hemophilia 2 trials · 8 incl. sub-types
3 sub-types
- Acquired hemophilia A 6 trials
- Acquired factor XI deficiency 0 trials
- Acquired hemophilia B 0 trials
-
Acquired von willebrand syndrome 3 trials
-
Acquired factor X deficiency 1 trial
-
Acquired factor V deficiency 0 trials
-
Acquired factor VII deficiency 0 trials
-
Acquired factor XIII deficiency 0 trials
-
New reversal agent TAK-330 aims to stop bleeding in emergency surgeries
Disease control Recruiting nowThis Phase 3 trial tests TAK-330, a drug designed to reverse the effects of common blood thinners (Factor Xa inhibitors) in patients who need urgent surgery. About 440 adults will be randomly assigned to receive TAK-330 or standard care before their procedure. The main goal is to…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New clotting drug may cut bleeding risk in rare cancer surgery
Disease control Recruiting nowThis study tests whether a concentrated clotting drug (fibrinogen) can better control major blood loss during surgery for pseudomyxoma peritonei, a rare abdominal cancer. About 90 adults will be randomly assigned to receive either the drug or a standard blood product during their…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a 5-Minute blood test save trauma patients from unnecessary treatment?
Knowledge-focused Recruiting nowThis study looks at whether a quick bedside test can measure fibrinogen levels in trauma patients with severe bleeding within minutes, instead of the usual 30-45 minutes. Fibrinogen helps blood clot, and low levels can worsen bleeding. The test is being checked for feasibility an…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC